Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B-Cell Non-Hodgkin's Lymphoma.
Journal: Clinical pharmacology in drug development
Published: January 27, 2022
The cumulative risk of jail incarceration.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 13, 2021
A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab-refractory iNHL (COMPLEMENT A + B study).
Journal: British journal of haematology
Published: November 17, 2020
Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study.
Journal: Blood cancer journal
Published: July 10, 2019
Showing 1-5 of 5
Last Updated: 09/26/2026